Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis

NCT07531069 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07531069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07531069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
May 21, 2024
Completion date
August 31, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult refractory secondary hemophagocytic lymphohistiocytosis, hlh, secondary hemophagocytic lymphohistiocytosis